Today’s news / Børsen

Børsen

The competition in the market for weight loss medication is intensifying. This has led to a 14 percent decrease in Novo Nordisk’s share price over a month. Particularly, the Swiss company Roche is weighing down Novo Nordisk’s market value, an analyst assesses.